Home › Stocks › ELDN › All Fund Holders
ELDN — ELEDON PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 31 · Reported value held: $72.85M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 5.12M | $20.19M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 2.51M | $9.89M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.96M | $7.71M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 4.04M | $6.10M | 0.00% | Add |
| Point72 Asset Management history | Q4 2024 | 1.09M | $4.51M | 0.01% | New |
| UBS Group AG history | Q2 2026 | 1.05M | $4.13M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 979.71K | $3.86M | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 883.10K | $3.48M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 616.40K | $2.43M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 581.03K | $2.29M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 510.67K | $2.01M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 485.09K | $1.91M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 247.40K | $974.77K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 200.90K | $791.55K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 166.93K | $657.69K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 76.64K | $301.97K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 74.94K | $295.28K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 59.30K | $233.63K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2025 | 61.52K | $208.55K | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 51.01K | $200.98K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 36.08K | $142.15K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 32.95K | $129.80K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 32.31K | $125.37K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 21.45K | $84.52K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 11.52K | $45.39K | 0.00% | Add |
| Marshall Wace history | Q4 2025 | 29.55K | $44.62K | 0.00% | New |
| CPP Investments history | Q4 2025 | 29.40K | $44.39K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 7.00K | $27.58K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 6.24K | $24.57K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 1.10K | $4.34K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 63.98K | $253 | 0.00% | Add |